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Background: Hemoglobin A1c (HbA1c) was adopted as a new standard criterion for diagnosing diabetes. We investigated 
the diagnostic utility of HbA1c by comparing the 2003 American Diabetes Association (ADA) diagnostic criteria of 
diabetes with HbA1c of 6.5%. Furthermore, the cut-off value for HbA1c was investigated using receiver operating 
characteristic curves.
Methods: This study included 224 subjects without a history of diabetes that had a fasting plasma glucose level of above 
100 mg/dL. The subjects had undergone a 75 g oral glucose tolerance test, and diabetes was deﬁ  ned as according to 2003 
ADA criteria.
Results: The prevalence of newly diagnosed diabetes was 58.2% by the 2003 ADA criteria, and 47.8% by HbA1c of 6.5%, 
which underestimated the prevalence of diabetes. Compared with the 2003 ADA criteria, the sensitivity and speciﬁ  city of 
HbA1c of 6.5% were 73.5% and 89.1%, respectively. The kappa index of agreement between 2003 ADA and HbA1c criteria 
was 0.60. The cut-off point of HbA1c for diagnosing diabetes was 6.45% (sensitivity, 73.3%; speciﬁ  city, 88.2%; area under 
the curve, 0.85). HbA1c was signiﬁ  cantly associated with fasting glucose (r = 0.82, P < 0.01), postprandial glucose (r = 0.78, 
P < 0.01), and homeostasis model assessment of insulin resistance (r = 0.16, P < 0.05).
Conclusion: For high risk patients whose fasting glucose was more than 100 mg/dL, HbA1c criterion underestimated the 
prevalence of newly diagnosed diabetes compared to the 2003 ADA criteria, and showed moderate agreement. The cut-
off value for HbA1c was 6.45%, which was similar to the recommended diagnostic criterion of HbA1c by the 2009 ADA.
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in Korea because of a change in life style and the westernization 
of eating habits.
1) In particular, at least 4-7 years passes before 
type 2 diabetes gets clinically diagnosed,
2) and 25% of diabetes 
patients are considered to have microvascular complications 
such as diabetic nephropathy, diabetic retinopathy, or diabetic 
neuropathy.
3,4) Since strict plasma glucose management from the 
early stage of diagnosis is important in preventing complications 
of diabetes, it is necessary to have adequate treatment immediately 
aft  er the early diagnosis.
5)
Currently in Korea, cases with abnormalities in fasting plasma 
glucose (FPG) and oral glucose tolerance test (OGTT) based 
on the diagnostic criteria suggested by the American Diabetes 
Association (ADA) in 2003 are diagnosed as diabetes.
6) In 2009, 
the International Expert Council of the ADA published a new 
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diagnostic criteria and hemoglobin A1c (HbA1c) was added to it 
as a diagnostic method of type 2 diabetes.
7,8) HbA1c displays high 
reproducibility compared with the FPG or OGTT, reflects the 
plasma glucose control condition for the most recent 2-3 month 
period, and off  ers the advantage of not needing to fast at the time 
of the test. In addition, HbA1c is also known as a bett  er predictive 
factor for diabetic retinopathy and cardiovascular disease.
9,10) Even 
though some reports suggest that HbA1c is useful in diagnosing 
diabetes,
5,9-11) other reports show that diagnostic usefulness is 
low because of the reduced sensitivity.
12,13) Therefore, there is a 
controversy over whether HbA1c is useful as diagnostic criterion 
of diabetes. In addition, there are few researches which investigate 
whether any changes occur in the diagnostic aspect of diabetes in 
Koreans by adding HbA1c to the previous diagnostic criteria.
Th   erefore, the fi  rst purpose of this study was to examine the 
diagnostic usefulness of HbA1c by analyzing the specifi  city and 
sensitivity of HbA1c compared with the specifi  city and sensitivity 
of the 2003 ADA criteria. Th   e second purpose of this study was to 
examine the changes of diagnostic aspects of diabetes by adding 
HbA1c to the 2003 ADA criteria.
METHODS
1. Participants
Out of 1,825 individuals who visited the outpatient Family 
Medicine Clinic of Dankook University Hospital and had a FPG 
≥ 100 mg/dL from May 2004 to December 2009, we included 
224 individuals in whom 75 g OGTT    was undertaken.
Th   e participants who were excluded from this study included 
those who had been previously diagnosed with diabetes or 
cancer, had a body temperature of 38.0
oC or more, white blood 
cell count of 10
5/L or more, and pyuria or hematuria, and who 
had infi  ltration in chest radiography. Patients who were pregnant, 
received blood transfusion within the last 6 months, had 
abnormal kidney, liver, and thyroid function, had hemoglobin of 
13 g/dL or less (male) or hemoglobin of 12 g/dL or less (female), 
were also excluded from this study because of the possible 
infl  uence of all these factors on HbA1c and insulin.
2. Measurements
Before 75 g OGTT was conducted, age, sex, and medical 
history related to diabetes in the past were examined in all 
patients, as well as blood pressure, height and weight. Blood 
pressure was measured when patients took a 5 minute rest in a 
chair with a back, and body mass index (BMI) was calculated 
by dividing body weight (kg) by square of height (m
2). All the 
patients underwent the basic fasting glucose test aft  er at least 10 
hours overnight fast or more. Th   e 75 g OGTT    was performed for 
patients with FPG ≥ 100 mg/dL. HbA1c was measured using 
high performance liquid chromatography (BioRad, Richmond, 
CA, USA) and its coeffi   cient of variation was 3%. Serum insulin 
concentration was measured with an immunoradiometric assay 
(Dream Gamma-10, Shinjin Medics Inc., Seoul, Korea), and 
its coefficient of variation was 2.1-4.5% of the intra-assay, and 
4.7-12.2% of the inter-assay. Total cholesterol, triglyceride, 
high density lipoprotein cholesterol, aspartate aminotransferase, 
alanine aminotransferase, and gamma-glutamyl transpeptidase 
were measured through an automatic analyzer (Hitachi Modular 
DP; Hatachi Ltd., Tokyo, Japan).
3. Definition
The definition of diabetes was determined as: 1) FPG ≥ 
126 mg/dL, or 2) 2-hour plasma glucose ≥ 200 mg/dL during 
OGTT   , according to the 2003 ADA criteria. As typical symptoms 
of diabetes were not examined, diagnosis was not made with this 
consideration. Th   e participants were defi  ned as impaired fasting 
glucose (IFG; FPG levels, 100 to 126 mg/dL), or impaired 
glucose tolerance (IGT; 2-hour values in the OGTT   , 140 to 200 
mg/dL).
6) As for HbA1c, according to the recommendation 
of 2009 ADA, patients with HbA1c < 5.7% were classified as 
normal, 5.7-6.4% as pre-diabetes, and ≥ 6.5% as diabetes.
14) For 
the index of insulin resistance, homeostasis model assessment of 
insulin resistance (HOMA-IR) index was used and calculated as 
follows
15): HOMA-IR = fasting insulin (μIU/mL) × FPG (mmol/
L) / 22.5.
4. Statistical Analysis
We expressed continuous variables as mean ± standard 
deviation (SD), and categorical variables as percentages. Receiver 
operating characteristic curves were generated to calculate 
sensitivity and specificity of HbA1c cut-off points for diabetes 
diagnosis. Th  e  kappa-coeffi   cients were used to test the agreement 
between HbA1c and blood glucose concentration (that is, FPG Hee-Jung Kim, et al: The Utility of HbA1c as a Diagnostic Criterion of Diabetes
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and two hour plasma glucose during OGTT  ).
Spearman’s correlation analysis was used to investigate the 
association of blood glucose concentrations with HbA1c and 
metabolic risk factors adjusted for age and sex. For statistical 
analysis, SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA) was used. 
Signifi  cance was defi  ned as P < 0.05.
RESULTS
The average age of the participants was 49.8 ± 10.5 years. 
There were 167 males (74.5%), and 57 females (25.5%). The 
average BMI was 25.4 ± 2.9 kg/m
2 (Table 1). According to the 
glucose tolerance status derived from OGTT   , 7.1% were classifi  ed 
as normal, 4.0% as IGT, 17.9% as both IGT and IFG, and 58.9% 
as newly diagnosed with diabetes. The glucose tolerance status 
within categories of HbA1c is shown in Table 2. Majority of 
the subjects (90.7%) with HbA1c ≥ 6.5% were also classified 
as diabetes by the OGTT   , whereas 9.3% of them were classifi  ed 
as pre-diabetes. For subjects in the pre-diabetes category by 
HbA1c, 56.2% were classifi  ed as pre-diabetes, 32.3% as diabetes, 
and 11.5% as normal glucose tolerance (NGT) by the OGTT. 
Only 23.8% of the subjects with HbA1c < 5.7% were classified 
as NGT, 57.2% as pre-diabetes, and 19.0% as diabetes by the 
OGTT   . HbA1c and IFG diagnosis showed a corresponding result 
in 156 persons, which represented 69.6% of the entire group of 
participants. Th   e concordance rate between HbA1c criteria and 
OGTT    was  69.6%.
The kappa index of agreement of 2003 ADA criteria with 
HbA1c criterion was 0.60, whereas that with FPG criterion was 
0.65, and that with 2-hour plasma glucose criterion was 0.89, 
which was the highest among these three criteria. The number 
of subjects newly diagnosed with diabetes according to the 2009 
ADA recommendation was 142 (63.4%) and the increase in 
prevalence by the additional application of HbA1c to the 2003 
ADA criteria was 7.6%. Area under curve (AUC) for HbA1c was 
0.86 (95% confidence interval [CI], 0.81 to 0.91), which was 
similar to AUC for FPG (0.89; 95% CI, 0.85 to 0.93) and lower 
than AUC for 2-hour plasma glucose (0.97; 95% CI, 0.94 to 0.99) 
(Table 1). The optimal threshold of HbA1c in identifying type 
2 diabetes was 6.45%, with a sensitivity of 73.3%, specificity of 
Table 1. Characteristics of the subjects (n = 224).
Characteristics Values
Age (y) 49.8 ± 10.5
Male 167 (74.5)
BMI (kg/m
2) 25.4 ± 2.9
Waist circumference (cm) 87.2 ±7.9
Systolic blood pressure (mm Hg) 129.5 ±13.7
Diastolic blood pressure (mm Hg) 82.4 ± 11.1
Total cholesterol (mg/dL) 203.6 ± 40.5 
Triglyceride (mg/dL) 206.0 ± 131.0
HDL-C (mg/dL) 49.6 ± 12.9
AST (IU/L) 29.1 ± 15.5
ALT (IU/L) 35.4 ± 23.9
r-GTP (IU/L) 70.2 ± 73
75 g OGTT 0 min (mg/dL) 128.3 ± 34.8
75 g OGTT 120 min (mg/dL) 218.0 ± 91.5
HbA1c (%) 6.9 ± 1.4
Insulin(µIU/mL) 10.2 ± 8.0
HOMA-IR 3.2 ± 2.7
Values are presented as mean ± SD, or number (%).
BMI: body mass index, HDL-C: high density lipoprotein chole-
sterol, AST: aspartate aminotransferase, ALT: alanine aminotrans-
ferase, r-GTP: gamma-glutamyl transpeptidase, OGTT: oral glucose 
tolerance test, HbA1c: hemoglobin A1c, HOMA-IR: homeostasis 
model assessment of insulin resistance.
Table 2. Glucose tolerance status according to the HbA1c categories 










Normal 5 (23.8) 11 (11.5) 0 (0.0) 16
IGT 2 ( 9.5) 7 (7.3) 0 (0.0) 9
IFG 4 (19.0) 22 (22.9) 1 (0.9) 27
IGT & IFG 6 (28.7) 25 (26.0) 9 (8.4) 40
Diabetes 4 (19.0) 31 (32.3) 97 (90.7) 132
Total 21 (100.0) 96 (100.0) 107 (100.0) 224
Values are presented as number (%).
HbA1c: hemoglobin A1c, IGT: impaired glucose tolerance, IFG: im-
paired fasting glucose.Hee-Jung Kim, et al: The Utility of HbA1c as a Diagnostic Criterion of Diabetes
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88.2%, positive predictive value of 99.3%, and negative predictive 
value of 23.2% (Figure 1).
Spearman’s correlation coeffi   cients of blood glucose concent-
rations with HbA1c and metabolic risk factors are shown in Table 
3. Spearman’s correlation coefficient of HbA1c with FPG and 
with 2-hour plasma glucose were similar (0.82, P < 0.01 and 0.78, 
P < 0.01, respectively) and that between FPG and 2-hour plasma 
glucose was 0.82 (P < 0.01) (Table 3). FPG showed signifi  cant 
correlation with triglyceride (r = 0.17, P < 0.05), systolic blood 
pressure (r = -0.16, P < 0.05), and HOMA-IR (r = 0.30, P < 
0.01). Two hour plasma glucose showed significant correlation 
with systolic blood pressure (r = -0.17, P < 0.05), diastolic blood 
pressure (r = -0.15, P < 0.05), and HOMA-IR (r = 0.2, P < 0.01). 
HbA1c showed statistically significant correlation with systolic 
blood pressure (r = -0.16, P < 0.05), diastolic blood pressure (r = 
-0.18, P < 0.05), total cholesterol (r = 0.16, P < 0.05), triglyceride 
(r = 0.21, P < 0.01), and HOMA-IR (r = 0.16, P < 0.05).
DISCUSSION
This study investigated the diagnostic usefulness of HbA1c 
criterion by comparing it with the 2003 ADA criteria among 
high risk subjects whose FPG was 100 mg/dL or more. The 
prevalence of newly diagnosed diabetes was 58.2% according to 
the 2003 ADA criteria, but 47.8% by HbA1c criterion, suggesting 
that HbA1c underestimated the prevalence of diabetes by 10.4% 
compared with 2003 ADA criteria. These results corresponded 
to recent research results.
16-18) Th   e prevalence of newly diagnosed 
diabetes in the US Nutritional Health & Nutrition Examination 
Survey (NHANES) study on 14,611 persons aged 20 or more 
was 5.0% by OGTT    and 1.8% by HbA1c, which underestimated 
the prevalence of diabetes by nearly 66% compared with OGTT  .
16) 
In a recent study of the residents of Qingdao, China, HbA1c 
diagnosed only 30% of the diabetes diagnosed by OGTT  ,
17) and 
the Rancho Bernado study also showed that the sensitivity of 
HbA1c was lower compared with that of OGTT.
18) Therefore, 
the results of this study and the previous studies suggest that 
diagnosing diabetes only through the HbA1c criterion is not 
Table 3. Spearman’s correlation coefficients for the relationship 
between glycemic measures as well as with other metabolic 
variables with adjustment for age and sex.
HbA1c FPG PP2
‡
BMI -0.13 -0.12 -0.06
Waist circumference (cm) -0.11 -0.08 -0.06
Systolic blood pressure (mm Hg) -0.16* -0.16* -0.17*
Diastolic blood pressure (mm Hg) -0.18* -0.08 -0.15*
Total cholesterol (mg/dL) 0.16* 0.11 0.04
Triglyceride (mg/dL) 0.21
† 0.17* 0.14
HDL-cholesterol (mg/dL) -0.03 -0.03 -0.05
AST (IU/L) -0.10 -0.07 -0.03
ALT (IU/L) -0.05 -0.03 0.00
r-GTP (IU/L) -0.11 -0.04 -0.03
75 g OGTT 0 min (mg/dL) 0.82
† - 0.82
†
75 g OGTT 120 min (mg/dL) 0.78
† 0.82
† -
HbA1c (%) - 0.82
† 0.78
†




HbA1c: hemoglobin A1c, FPG: fasting plasma glucose, PP2: protein 
phosphatase 2, BMI: body mass index, HDL: high-density 
lipoprotein, AST: aspartate aminotransferase, ALT: alanine 
aminotransferase, r-GTP: gamma-glutamyl transpeptidase, OGTT: 
oral glucose tolerance test, HOMA-IR: homeostasis model 
assessment of insulin resistance.
*P < 0.05. 
†P < 0.01. 
‡PP2: two hour plasma glucose during 75 g 
OGTT.
Figure 1. Receiver operating characteristic (ROC) curves for 
hemoglobin A1c (HbA1c) in identifying subjects with diabetes by 
the 2003 American Diabetes Association (ADA) criteria. Diagnal 
segments are produced by ties. FPG: fasting plasma glucose, PP2: 
two hour plasma glucose during 75 g oral glucose tolerance test.Hee-Jung Kim, et al: The Utility of HbA1c as a Diagnostic Criterion of Diabetes
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recommended because there is the possibility that the prevalence 
of diabetes may be underestimated by using just HbA1c criterion.
In a situation where the prevalence of diabetes is increasing, 
as seen in Korea, diagnosing diabetes only through the HbA1c 
criterion may delay the early diagnosis of diabetes, which results 
in a diff  erent treatment goal for cardiovascular risk factors such as 
cholesterol, triglyceride, and blood pressure, and the frequency 
of complications of diabetes is expected to increase. Therefore, 
diabetes should be diagnosed with HbA1c and plasma glucose 
together.
When subjects were classified into normal, pre-diabetes 
and diabetes according to the criteria of plasma glucose and 
HbA1c respectively, 90.7% of diabetic subjects by HbA1c were 
also diabetic by OGTT, but 9.3% of them were pre-diabetic 
by just OGTT. Only 56.2% of HbA1c assessed pre-diabetic 
subjects were pre-diabetic by OGTT   , and only 23.8% of HbA1c 
assessed normal subjects were normal by OGTT, indicating 
that the concordance rate of HbA1c and OGTT diagnosis was 
69.6%. OGTT    missed 9.3% of the diabetic subjects detected by 
HbA1c, but HbA1c missed 26.5% of diabetic subjects detected 
by OGTT  .  Th  is  diff  erence in diagnostic methods is presumed to 
refl  ect the diff  erent physiological aspects of plasma glucose.
14) It 
is thought that a prospective cohort study is needed to investigate 
whether there is any difference in the incidence rate of diabetic 
complications depending on diagnostic methods.
Until now, Korean reports showed various cut-off values 
(5.3-6.4%) of HbA1c for diagnosing diabetes.
19-23) Bae et al.
20) 
conducted the OGTT    on 1,482 subjects not yet diagnosed with 
diabetes, and reported that the cut-off   value of HbA1c was 5.95% 
(sensitivity, 60.8%; specificity, 85.6%). Kim et al.
24) conducted 
the OGTT on 392 persons who had IFG or were in the high 
risk group, and reported that the cut-off value of HbA1c was 
6.1% (sensitivity, 81.8%; specifi  city, 84.9%). Th  e  cut-off   value of 
HbA1c in this study was 6.45%. Th   e reason why the cut-off   value 
of HbA1c was reported diff  erently in these studies was most likely 
due to differences in the subjects’ age, method of recruitment, 
gold standard for diagnosis of diabetes, and risk factors such as 
obesity.
25) The study for the proper cut-off value of HbA1c for 
diagnosing diabetes should be conducted among representative 
Korean people such as Korean NHANES (KNHANES).
In this study, HbA1c showed significant relationships with 
metabolic risk factors, including systolic blood pressure, diastolic 
blood pressure, triglyceride, total cholesterol, and HOMA-IR, but 
the degree of these relationships was not very high (Spearman’s 
correlation coeffi   cient of 0.2). Th   e relationship of metabolic risk 
factors with FPG or with 2-hour plasma glucose was similar to 
that with HbA1c. Th   is result supports the observation that HbA1c 
and cardiovascular risk factors have a significant relationship,
26) 
and it corresponds with previous reports showing that HbA1c is 
superior or similar to FPG or 2-hour plasma glucose in predicting 
death rate from cardiovascular disease.
10,27) Lorenzo et al.
28) 
conducted OGTT    and examined the association of HbA1c with 
FPG, 2-hour plasma glucose, and metabolism risk factors on 385 
adults who had IGT, IFG or HbA1c of 5.7-6.4%. Th  ey  showed 
that HbA1c had lower correlation coefficients with metabolic 
risk factors than with FPG or 2-hour plasma glucose. It is diffi   cult 
to directly compare our study with theirs because their research 
was limited to subjects with HbA1c of 5.7-6.4%. In this study, a 
negative correlation of HbA1c with systolic blood pressure and 
diastolic blood pressure was found.
29) We believe this was because 
factors such as anti-hypertensive medication were not adjusted. 
Further research should be done aft  er adjusting such factors.
Th   ere were a few limitations to this study. First, the prevalence 
of diabetes was relatively high because this study was conducted 
on the high risk group with FPG ≥ 100 mg/dL, and it was diffi   cult 
to generalize the results of this study since the analysis was done 
on a relatively small number of subjects. However, considering 
that the OGTT    was conducted mainly on subjects with high FPG, 
it would be appropriate for the results of this study to be applied 
clinically. Second, this study was done on only 224 subjects in 
whom 75 g OGTT was undertaken out of 1,825 persons with 
FPG ≥ 100 mg/dL. An analysis of the diff  erence in metabolic risk 
factors was not conducted. Th   ird, FPG or random plasma glucose 
should be measured twice or more on diff  erent days at the time 
of diagnosis diabetes, but in this study diagnosis of diabetes was 
done by conducting OGTT once. However, this study has an 
advantage that it examined the diagnostic usefulness of HbA1c by 
comparing HbA1c, a new diagnostic criterion for diabetes, with 
OGTT  .
In conclusion, HbA1c in the high risk group of diabetes 
with increased FPG underestimated the prevalence of diabetes, 
but showed moderate agreement with 2003 ADA criteria. The 
appropriate cut-off   value of HbA1c was 6.45%, which was similar 
to the recommended diagnostic criterion of HbA1c by 2009 ADA.Hee-Jung Kim, et al: The Utility of HbA1c as a Diagnostic Criterion of Diabetes
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